Grant of Employee Stock Options
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty 100 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Reddy's Laboratories has granted employee stock options under two schemes following approval by its Nomination, Governance and Compensation Committee on May 8-9, 2025. A total of 9,15,763 Indian stock options were granted at an exercise price of Rs. 1,162 per share under the 2018 ESOP Scheme, along with 3,53,057 ADR stock options at the same exercise price under the 2007 ADR ESOP Scheme. Both grants carry a 100% vesting schedule over 3 years and are priced at fair market value. The combined grant of 12,68,820 options represents a modest dilution to existing shareholders.
This is a routine ESOP grant at fair market value with a 3-year vesting period, so it is unlikely to move the stock price meaningfully. Shareholders should note a slight potential dilution, but the grant aligns employee incentives with long-term shareholder value creation.